Suresh S. Ramalingam

home / contributors / suresh-s-ramalingam

Articles

Suresh Ramalingam on Toxicities Associated With Immunotherapy in Different Disease Types

Suresh Ramalingam on Toxicities Associated With Immunotherapy in Different Disease Types

Suresh S. Ramalingam
August 21st 2015

Suresh S. Ramalingam, a professor of medical oncology at the Winship Cancer Institute of Emory University, comments on the difference in toxicities associated with immunotherapy.

Read More

Suresh Ramalingam on Side Effects Associated With Immunotherapy in Lung Cancer

Suresh Ramalingam on Side Effects Associated With Immunotherapy in Lung Cancer

Suresh S. Ramalingam
August 21st 2015

Suresh S. Ramalingam, a professor of medical oncology at the Winship Cancer Institute of Emory University, discusses side effects associated with immunotherapy in lung cancer.

Read More

Latest Updated Articles

Image of man and doctor.
Published: April 12th 2025 | Updated: April 30th 2025
NeuroSAFE May Increase Erectile Function After Prostate Cancer Surgery
The FDA has approved penpulimab-kcqx with chemotherapy and as a single agent for some patients with nasopharyngeal carcinoma: © stock.adobe.com.
Published: April 24th 2025 | Updated: April 30th 2025
FDA Approves Penpulimab-kcqx For Nasopharyngeal Carcinoma
People can help EBCI reach their goal of $20,000 dollars raised for GiveBIG 2025 by giving at endbraincancer.org/donate: © stock.adobe.com.
Published: April 22nd 2025 | Updated: April 30th 2025
Support Patient Access and Education with the End Brain Cancer Initiative for GiveBIG 2025
The End Brain Cancer Initiative is currently seeking Primary Central Nervous System Lymphoma patients and care partners to participate in an online roundtable discussion: © stock.adobe.com.
Published: March 3rd 2025 | Updated: April 30th 2025
Primary Central Nervous System Lymphoma Patient and Care Partner Roundtable Hosted by the End Brain Cancer Initiative
Registration is now open for the 2025 Know All Your Treatment Options (KAYTO25) online patient disease education event/webinar: © stock.adobe.com.
Published: March 17th 2025 | Updated: April 30th 2025
Registration Open for the 2025 Know All Your Treatment Options Webinar Hosted by the End Brain Cancer Initiative
Each May, for over a decade, the End Brain Cancer Initiative (EBCI) has presented the National HOPE Award to a brain cancer patient who deeply inspires us: © stock.adobe.com.
Published: March 18th 2025 | Updated: April 30th 2025
Nominations Open for the End Brain Cancer Initiative’s 2025 National Patient Disease Education Initiative and HOPE Award